JusticeItaly Official institution
Italy authorizes parallel import of medicine Ducressa
Italy's medicines regulator, the Agenzia Italiana del Farmaco (AIFA), has published a notice authorizing the parallel import of the human medicine Ducressa, dated 3 November 2026. Parallel import means a medicine already approved in another country is brought into Italy under a separate Italian permit. The notice is listed under reference 26A05707, and the document excerpt does not give further details.
This summary was generated by AI; the official source prevails.
What does it mean?
In plain terms, a medicine that is already approved in another country can now be brought into Italy and sold there under a separate Italian permit. This notice covers the medicine Ducressa.